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Background: Mathematical modeling constitutes an important tool for planning robust 
responses to epidemics. This study was conducted to guide the Qatari national response to the 
severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) epidemic. The study 
investigated the time course of the epidemic, forecasted healthcare needs, predicted the impact of 
social and physical distancing restrictions, and rationalized and justified easing of restrictions. 
Methods: An age-structured deterministic model was constructed to describe SARS-CoV-2 
transmission dynamics and disease progression throughout the population.  
Results: The enforced social and physical distancing interventions flattened the epidemic curve, 
reducing the peaks for incidence, prevalence, acute-care hospitalization, and intensive care unit 
(ICU) hospitalizations by 87%, 86%, 76%, and 78%, respectively. The daily number of new 
infections was predicted to peak at 12,750 on May 23, and active-infection prevalence was 
predicted to peak at 3.2% on May 25. Daily acute-care and ICU-care hospital admissions and 
occupancy were forecast accurately and precisely. By October 15, 2020, the basic reproduction 
number 0R  had varied between 1.07-2.78, and 50.8% of the population were estimated to have 
been infected (1.43 million infections). The proportion of actual infections diagnosed was 
estimated at 11.6%. Applying the concept of tR  tuning, gradual easing of restrictions was 
rationalized and justified to start on June 15, 2020, when tR  declined to 0.7, to buffer the 
increased interpersonal contact with easing of restrictions and to minimize the risk of a second 
wave. No second wave has materialized as of October 15, 2020, five months after the epidemic 
peak.  
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Conclusions: Use of modeling and forecasting to guide the national response proved to be a 
successful strategy, reducing the toll of the epidemic to a manageable level for the healthcare 
system.   
Keywords: SARS-CoV-2, COVID-19, coronavirus, epidemiology, Qatar, mathematical model, 
healthcare 
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Mathematical modeling has become a fundamental tool to guide surveillance of infectious 
diseases and emergency responses to epidemics [1-3]. Powered by surveillance and outbreak 
data, infection transmission models help monitor and predict epidemiological trends using real-
time estimation of key indicators, such as incidence of infection, severe and critical disease 
cases, disease mortality, and basic reproduction number (
0R ; the number of secondary infections 
each infection would generate in a fully susceptible population [4]) [3]. 
Qatar is a peninsula located in the Arabian Gulf, with a diverse population of 2.8 million people 
[5]. Like other countries, Qatar has been affected by the severe acute respiratory syndrome 
coronavirus 2 (SARS-CoV-2) pandemic [6-9]. Yet, the nation mounted an evidence-informed 
national response, in which in addition to early case identification, isolation, and quarantine 
through contact tracing, diverse standardized and centralized sources of data were generated, 
including population-based surveys. This wealth of data provided a special opportunity to 
understand infection transmission dynamics, predict healthcare needs associated with the 
resulting disease, coronavirus disease 2019 (COVID-19) [10], and to inform the global 
epidemiology of this infection. 
Qatar has a unique socio-demography that affected the transmission patterns of SARS-CoV-2 
[8,11], a respiratory infection that propagates through social networks. Nearly 90% of the 
population are expatriates [5,12,13] with craft and manual workers (CMWs) constituting 60% of 
the population [14]. Of the national subpopulations, Indians (28%) constitute the largest 
population segment, followed by Bangladeshis (13%), Nepalese (13%), Qataris (11%), 
Egyptians (9%), and Filipinos (7%) [13]. The CMW population is predominantly male, single, 
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and young, with the top three countries of origin being India, Bangladesh, and Nepal [14]. Most 
CMWs live in shared housing accommodations akin to dormitories [15]. 
This study was conducted to describe SARS-CoV-2 transmission dynamics in Qatar and to craft 
a national response using mathematical modeling of the epidemic time-course, predicting the 
impact of social and physical distancing restrictions and the impact of easing those restrictions, 
and forecasting healthcare needs, in terms of hospitalizations requiring acute-care and intensive 
care unit (ICU) beds. The study was initiated before the identification of the first laboratory-
confirmed case of community transmission on March 6, 2020, and has continued to provide real-
time projections and forecasts since then.  
The overarching aim of the present article was to provide the technical tools and a “case study” 
to demonstrate how individual countries can use mathematical modeling to effectively craft 
national public-health responses and to formulate evidence-based policy decisions that minimize 
the epidemic’s toll on morbidity, mortality, societies, and economies.       
Methods 
Mathematical model 
Building on our previously developed models [8,16-19], an age-structured, meta-population, 
deterministic mathematical model was constructed to describe SARS-CoV-2 transmission 
dynamics and disease progression (Figure S1 of Supplementary Material (SM)). The model 
stratified the Qatari population into groups (“compartments”) according to the major nationality 
groups (Indians, Bangladeshis, Nepalese, Qataris, Egyptians, Filipinos, and all other 
nationalities), age group by decile, infection status (infected, uninfected), severity of illness 
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(asymptomatic/mild, severe, critical), and disease/hospitalization stage (severe, critical), using 
sets of coupled, nonlinear, differential equations. A detailed description of the model is available 
in the SM. 
The risk of acquiring the infection varied between susceptible populations based on nationality, 
infectious contact rate per day, age-specific exposure/susceptibility to the infection, and 
subpopulation-mixing and age-mixing matrices parametrizing the mixing between individuals in 
different nationality and age groups. Following a latency period, infected individuals in the 
model develop an asymptomatic/mild, severe, or critical infection. The age-dependence of the 
proportions of infected persons developing asymptomatic/mild, severe, or critical infections was 
based on the modeled SARS-CoV-2 epidemic in France [20]. Severe and critical infections 
progress to severe and critical disease, respectively, prior to recovery. Patients are hospitalized in 
acute-care and ICU-care beds, respectively, based on existing standards of care in Qatar. Critical 
disease cases have an additional risk of COVID-19 mortality.  
The model was parameterized using the best available data for SARS-CoV-2 natural history and 
epidemiology. A detailed description of model parameters, definitions, values, and justifications 
is found in Tables S1-S2 in the SM. The size and demographic structure of the population of 
Qatar were based on a population census conducted by Qatar’s Planning and Statistics Authority 
[5]. Life expectancy was obtained from the United Nations World Population Prospects database 
[21]. 
Model fitting and analyses 
The model was fitted to the standardized and centralized databases of SARS-CoV-2 testing, 
infections, hospitalizations, and mortality [8], as well as to findings of ongoing epidemiologic 
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studies [8,11,22,23]. Data included: 1) time-series of the number of polymerase chain reaction 
(PCR)-confirmed SARS-CoV-2 cases, 2) time-series of the SARS-CoV-2 testing PCR positivity 
rate in each national subpopulation, 3) time-series of the PCR positivity rate in symptomatic 
patients with suspected SARS-CoV-2 infection coming to primary healthcare centers, 4) time-
series of the proportion of laboratory-confirmed SARS-CoV-2 cases aged >60 years, 5) time-
series of new/daily hospital admissions in acute-care beds and ICU-care beds, 6) the proportion 
of acute-care cases subsequently transferred to ICUs , 7) time-series of hospital occupancy in 
acute-care and ICU-care beds, 8) the cumulative number of deaths (not time series, due to the 
relatively small number of deaths), 9) a community survey assessing active-infections using 
PCR, 10) age-distribution of antibody positivity [8,22,23], and 11) national subpopulation 
distribution of antibody positivity [8,22,23]. A nonlinear least-square data fitting method, based 
on the Nelder-Mead simplex algorithm, was used to conduct the model fitting [24]. 
Model fitting was used to estimate epidemiologic indicators such as incidence, prevalence, attack 
rate (proportion of the population ever infected), and 
0R , as well as to forecast acute-care and 
ICU-care hospital admissions and hospital bed occupancy. The model was further used to 
evaluate the impact of implemented social and physical distancing restrictions by comparing 
model projections of the actual epidemic to those in a counter-factual scenario in which such 
interventions were not enforced. Informed by global estimates of 0R  in the early epidemic that 
ranged between 2-4 [25,26], the counter-factual scenario with no interventions was implemented 
assuming 0 3R = . The model was also used to predict the impact of different scenarios for easing 
of social and physical distancing restrictions. 
Uncertainty analysis 
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Five hundred simulation runs were conducted to determine the range of uncertainty attending 
model predictions. At each run, Latin Hypercube sampling was applied in selecting input 
parameter values [27,28] from pre-specified ranges that assume ±30% uncertainty around 
parameter point estimates. The model was then refitted to input data. The resulting distribution 
for each model prediction, based on the 500 runs, was used to derive the mean and 95% 
uncertainty interval (UI).  
Mathematical modeling analyses were conducted in MATLAB R2019a (Boston/MA/USA) [29] 
whereas statistical analyses were performed in STATA/SE 16.1 (College Station, TX) [30].  
Results 
The model fitted the various data sources (examples in Figures S2-S3). Figure 1 shows model 
predictions for evolution of SARS-CoV-2 incidence, cumulative incidence, active-infection 
prevalence, and attack rate in the total population. Peak incidence was estimated at 12,750 new 
infections on May 23, 2020 while peak prevalence was estimated at 3.2% on May 25, 2020. By 
October 15, 2020, an estimated 1,426,500 infections were projected to have occurred, for a 
proportion of the population infected of 50.8%. Also by October 15, 2020, the proportion of all 
infections that had actually been diagnosed and confirmed by PCR was estimated at 11.6%. 0R  
varied between 1.07-2.78 from March 1 to October 15, with the highest values reached well after 
the onset of easing of restrictions on June 15, 2020 (Figure S4A of SM). 
Figure 2A-2B shows model-predicted daily hospital admissions in acute-care and ICU-care beds, 
respectively. New hospital admissions were predicted to peak at 292 acute-care beds on May 22, 
2020 and 23 ICU-care beds on May 27, 2020. Figure 2C-2D shows evolution of hospital 
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occupancy in acute-care and ICU-care beds. Peaks were predicted at 1,910 acute-care beds on 
May 27, 2020 and 244 ICU-care beds on June 6, 2020. The average hospital stay in an acute-care 
bed was estimated at 7.7 days while the stay in an ICU-care bed was estimated at 14.0 days. 
These model predictions agreed with actual COVID-19 hospital admission data (Figure S3 of 
SM).  
Discussions with policymakers to plan easing of social and physical distancing restrictions were 
initiated in April of 2020. The effective reproduction number ( tR ), the number of secondary 
infections each infection is generating at a given time, t , heavily influenced these discussions. 
Based on the model-predicted evolution of tR  at that time (Figure 3A), it was advised that no 
easing of restrictions should occur before the epidemic peak, then predicted to occur on May 20, 
as the epidemic was still in its exponential growth phase ( 1tR  ). Model simulations confirmed 
that premature easing of restrictions would result in epidemic amplification (Figure 3B). To 
minimize the likelihood of a second wave and to buffer against a potential increased contact rate 
in the population, it was advised that easing of restrictions should not start before tR  reached 
0.70, and that easing of restrictions should be implemented gradually over at least two months. 
Model simulations confirmed this rationale, and indicated that gradual easing of restrictions after 
tR  reached 0.70 would minimize the risk of a second wave (Figure 3C). Accordingly, 
policymakers planned and subsequently implemented a gradual easing of restrictions starting 
June 15, 2020, the day on which tR  was predicted to decline to 0.7. This line of analysis and 
rationale proved successful, as no second wave had materialized as of October 15, 2020, five 
months after the epidemic peak (Figure 3D). 
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Figures 4 and S5 (SM) show the predicted evolution of the epidemic in the counter-factual 
scenario of no social and physical distancing interventions. In the absence of these interventions, 
the epidemic would have peaked at 97,100 new infections per day on April 3, 2020 (Figure 4A), 
and at a prevalence of 23.4% on April 5, 2020 (Figure 4B). New hospital admissions would have 
peaked at 1,235 acute-care bed admissions on April 7, 2020 (Figure 4C) and at 103 ICU-care bed 
admissions on April 10, 2020 (Figure 4D). Accordingly, by October 15, 2020, the enforced 
social and physical distancing restrictions reduced the peaks for incidence, prevalence, and 
acute-care and ICU-care hospital admissions by >75% (Figure 4A-4D), and averted 840,000 
infections (37%; Figure S5A of SM), 209 deaths (46%; Figure S5B of SM), 10,110 acute-care 
hospital admissions (32%; Figure S5C of SM), and 1,056 ICU-care hospital admissions (34%; 
Figure S5D of SM). These results show the extent of flattening of the epidemic curve that was 
accomplished with the enforced social and physical distancing interventions.    
Figure S6 of SM shows the results of the uncertainty analysis for the key epidemiological 
indicators in Figure 1, and Figure S7 of SM shows the results of the uncertainty analysis for the 
key hospitalization indicators in Figure 2. The results indicated overall narrow uncertainty 
intervals confirming the model’s predictive power. 
Discussion 
Our study demonstrates that mathematical modeling was influential in informing the national 
public-health response and in formulating evidence-based policy decisions to minimize the 
pandemic’s toll on health, society, and the economy. The model, which was implemented in real-
time, starting from March 2020, and was continuously updated and refined as more data became 
available, predicted with reasonable accuracy and precision the key epidemiologic indicators, 
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such as the epidemic peak and the impact of easing of restrictions, as well as healthcare needs, at 
a time of uncertainty in which knowledge of the epidemiology of this infection was growing but 
still limited.  
One of the highlights of this modeling approach is the application of the concept of rational tR  
tuning for managing the easing of restrictions (Figure 4). Grounded on a theoretical foundation 
[4], rational tR  tuning proved to be a successful and effective strategy in safely easing the 
restrictions so as to ensure social and economic stability and functionality, while minimizing the 
risk of a second wave (Figure 3). Another highlight is the estimation of healthcare needs that 
guided resource-allocation planning well before the time when these resources were needed. 
Throughout the epidemic, including the epidemic peak, healthcare needs in Qatar remained well 
within the health system capacity, avoiding any serious strain. Importantly, this forecasting of 
healthcare needs also prevented resource waste by avoiding overestimation of healthcare needs.   
Despite the large number of infections in Qatar, results show that the epidemic would have been 
far worse if no social and physical distancing interventions had been enforced. In absence of 
interventions, the epidemic would have progressed very rapidly to a peak nearly 10-fold higher 
than what was actually observed (Figure 4). Disease burden would have been much larger and 
the healthcare system would have been strained to the point of collapse. This demonstrates that 
for a respiratory infection with such large 0R  and serious disease sequalae, inaction would have 
had dire consequences, and that the national strategy focused on flattening the epidemic curve 
was appropriate to manage the epidemic.     
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An important finding of this study is that PCR-confirmed infections constitute only a small 
fraction of the actual number of infections. Only 11.6% of infections were estimated to have ever 
been diagnosed, probably because most infections were asymptomatic or mild. Indeed, a nation-
wide population-based survey in Qatar showed that 58.5% of those who were PCR positive in 
this survey reported no symptoms during the last two weeks preceding the survey [8]. The 
growing number of serological testing studies in Qatar have also shown that the vast majority of 
those who are antibody-positive were never diagnosed with this infection [8,11,22,23]. For 
instance, out of all those antibody-positive in a nation-wide seroprevalence survey of the CMW 
population, only 9.3% had a documented, PCR-confirmed infection prior to antibody testing, 
affirming that as estimated by the model, nine of every 10 infections were never diagnosed. 
These findings are also consistent with a growing body of serological evidence from other 
countries [31-35].   
We found that >97% of infections estimated to have occurred did not require hospitalization. The 
low infection severity appears to be a consequence of the young age profile of the population, 
with only 2% being >60 years of age [5,8,17,36], in addition to a well-funded healthcare system 
that emphasizes a proactive, high-quality standard of care [8], and possibly high levels of T cell 
cross-reactivity against SARS-CoV-2, reflecting T cell memory of circulating ‘common cold’ 
coronaviruses [37-41]. 
This study has limitations. Model estimates are contingent on the validity and generalizability of 
input data. Our estimates were based on current SARS-CoV-2 natural history and disease 
progression parameters, but our understanding of this infection is still evolving. Available input 
data were most complete at the national level. We did not have sufficient data about social 
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networks of different national subpopulations and patterns of mixing between those 
subpopulations to factor them into the model. Despite these limitations, our model, tailored to the 
complexity of the epidemic in Qatar, was able to reproduce observed epidemic trends, and to 
provide useful and consequential predictions and insights about infection transmission and 
healthcare needs. Importantly, the modeling estimates successfully influenced the national 
response.   
In conclusion, Qatar experienced a large SARS-CoV-2 epidemic, but avoided a burdensome 
epidemic, such as that unfolding in other counties. Mathematical modeling played an influential 
role in guiding the national public-health response by characterizing and understanding the 
epidemic, forecasting healthcare needs, predicting the impact of social and physical distancing 
restrictions, and rationalizing and justifying the easing of restrictions. While this article 
illustrates a successful case study, the modeling tools employed here can be adapted and applied 
in other countries to guide SARS-CoV-2 epidemic control, preparedness for the current or future 
waves of infection, or enforcement and easing of restrictions or other interventions, such as 
vaccination [19].    
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Figure 1. Model predictions for evolution of SARS-CoV-2 A) incidence (number of daily new 
infections), B) cumulative number of infections, C) active-infection prevalence (those latently infected or 
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Figure 2. Model predictions for evolution of COVID-19 A) daily hospital admissions in acute-care beds, 
B) daily hospital admissions in ICU-care beds, C) cumulative number of hospitalizations in acute-care 
beds, D) cumulative number of hospitalizations in ICU-care beds, E) hospital occupancy of COVID-19 
patients (number of beds occupied at any given time) in acute-care beds, and F) hospital occupancy of 
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Figure 3. A) Effective reproduction number Rt and easing of social and physical distancing restrictions. 
B) Prediction of the number of daily new infections with early easing of restrictions, three weeks before 
the epidemic peak. C) Prediction of the number of daily new infections with delayed easing of 
restrictions, three weeks after the epidemic peak. This figure demonstrates the rationale and criteria used 
for the start of easing of restrictions. The figure shows the model fit and results at the time when the 
policy decision was actually made. An updated prediction for Rt is in Figure S4 of SM. The figure also 
shows in D) the number of daily new diagnosed and laboratory-confirmed infections. 
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Figure 4. Impact of social and physical distancing interventions on A) number of daily new infections, B) 
active-infection prevalence (those latently infected or infectious), C) daily hospital admissions in acute-
care beds, and D) daily hospital admissions in ICU-care beds. 
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I. SARS-CoV-2 mathematical model structure 
A deterministic age-structured meta-population compartmental model was developed to describe 
the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) transmission dynamics and 
disease progression in the population of Qatar, factoring subpopulation heterogeneity in exposure 
to the infection. The model stratified the population into compartments according to nationality 
subpopulation, age group (0-9, 10-19, 20-29,…, ≥80 years), infection status (infected, 
uninfected), infection stage (asymptomatic/mild, severe, critical), and disease stage (severe 
disease or critical disease). All Coronavirus Disease 2019 (COVID-19) mortality was assumed to 
occur in individuals that are in the critical disease stage. The model is based on extension and 
adaptation of our calibrated mathematical models developed to characterize SARS-CoV-2 
transmission dynamics [1-5]. 
Epidemic dynamics were described using a system of coupled nonlinear differential equations 
for each age group and subpopulation (nationality) group. Each age group, a , denoted a ten-year 
age band apart from the last category which grouped together all individuals ≥80 years of age. 
The population was divided into seven resident subpopulation groups i  ( )1,2,3,4,5,6,7i =  
representing the subpopulations of Indians, Bangladeshis, Nepalese, Qataris, Egyptians, 
Filipinos, and all other nationalities, respectively—these are the largest nationality subpopulation 
groups in Qatar. Qatar’s population composition and subpopulations size and demographic 
structure were based on findings of “The Simplified Census of Population, Housing, and 
Establishments” conducted by Qatar’s Planning and Statistics Authority [6]. Life expectancy was 
obtained from the United Nations World Population Prospects database [7].  
All rights reserved. No reuse allowed without permission. 
preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. 
The copyright holder for thisthis version posted November 10, 2020. ; https://doi.org/10.1101/2020.11.08.20184663doi: medRxiv preprint 
3 
 
Figure S1. Schematic diagram describing the basic structure of the SARS-CoV-2 mathematical model. 
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The model was expressed in terms of the following system of coupled nonlinear differential 
equations for each subpopulation group and age group: 
( ) ( ) ( )( )
( , )
1 ( 1, ) , ( , )
dS a i
a S a i a i a S a i
dt
   = − − − + +  
( ) ( ) ( ) ( )( )
( , )
1 ( 1, ) , , ( , )
dE a i
a E a i a i S a i a E a i
dt
    = − − + − + +   
( ) ( ) ( ) ( )( )/ / / /
( , )
1 ( 1, ) , ( , )A M A M A M AD A M
dI a i
a I a i f a E a i a I a i
dt
    = − − + − + +  
( ) ( ) ( )( )
( , )
1 ( 1, ) ( ) , ( , )S S S SD S
dI a i
a I a i f a E a i a I a i
dt
    = − − + − + +  
( ) ( ) ( )( )
( , )
1 ( 1, ) ( ) , ( , )C C C CD C
dI a i
a I a i f a E a i a I a i
dt
    = − − + − + +  
( ) ( ) ( )( )
( , )
1 ( 1, ) , ( , )S S SD S S SC S
dD a i
a D a i I a i a D a i
dt
     = − − + − + + +  
( ) ( ) ( ) ( ) ( )( )
( , )
1 ( 1, ) , , ( , )C C CD C SC S C C
dD a i
a D a i I a i D a i a a D a i
dt
      = − − + + − + + +  
( ) ( )( )/ /
( , )
1 ( 1, ) ( , ) ( , ) ( , ) ( , )A M A M S S C C
dR a i
a R a i I a i D a i D a i a R a i
dt
     = − − + + + − +  
The definitions of population variables and symbols used in the equations are in Table S1. 
Table S1. Definitions of population variables and symbols used in the model 
Symbol Definition 
( , )S a i  Susceptible population  
( , )E a i  Latently infected population  
( )/ ,A MI a i  Population with asymptomatic/mild infection 
( ),SI a i  Population with severe infection 
( ),CI a i  Population with critical infection 
( ),SD a i  Population with hospitalization in acute-care beds 
( ),CD a i  Population with hospitalization in intensive care unit beds 
( , )R a i  Recovered population 
agen   Number of age groups 
popn   Number of subpopulation groups 
( )a  Transition rate from one age group to the next age group. Here (0) ( ) 0agen = =  
( )a  Susceptibility profile to the infection in each age group  
( )i  Level of exposure profile in each subpopulation group i   
1/  Duration of latent infection 
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  Average rate of infectious contacts  
1/ AD  Duration of asymptomatic/mild infection infectiousness 
1/ SD  Duration of severe infection infectiousness before isolation and/or hospitalization  
1/ S  Duration of severe disease following onset of severe disease  
1/ CD  Duration of critical infection infectiousness before isolation and/or hospitalization  
1/ C  Duration of critical disease following onset of critical disease  
1/ SC  Rate of disease progression from severe disease to critical disease 
( )a  Disease mortality rate in each age group  
1/   Natural death rate 
/ ( )A Mf a  Proportion of infections that will progress to be asymptomatic/mild infections  
( )Sf a  Proportion of infections that will progress to be infections that require hospitalization in 
acute-care beds 
( )Cf a  Proportion of infections that will progress to be infections that require hospitalization in 
intensive care unit beds 
Z  The subpopulation mixing matrix 
H  The age-mixing matrix 
The force of infection ( , )a i  (hazard rate of infection) experienced by each susceptible ( , )S a i  
population, is given by 
( ) ( ) ( ) /, ' , ', '
' 1 ' 1 /
( ', ') ( ', ') ( ', ')
,
( ', ') ( ', ') ( ', ') ( ', ') ( ', ')
( ', ') ( ', ') ( ', ')
age popn n
A M S C
i i a a i
a i A M S C
S C
I a i I a i I a i
a i i a Z H
S a i E a i I a i I a i I a i





+ + + + 
 
+ + + 
  
Here   is the rate of infectious contacts, ( )i  is the level of exposure profile in each 
subpopulation group i , and ( )a  is the susceptibility profile to the infection in each age group 
a .  
To account for temporal variation in the basic reproduction number (
0R  ), we incorporated 
temporal changes in the rate of infectious contacts. We parameterized the temporal variation 
(time dependence of  ) through the following combined function of the Woods-Saxon and 
logistic functions.  
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This function was mathematically designed to describe and characterize the time evolution of the 
level of risk of exposure before and after easing of restrictions. It was informed by our 
knowledge of SARS-CoV-2 epidemiology in Qatar [4], and it provided a robust fit to the data. 
Here 
1a , 2a , 1b , 2b , 1c , and 2c  are fitting parameters. 
The mixing among the different age groups and subpopulation groups is dictated by the mixing 
matrices , ', 'a a iH  (for age group mixing) and ,i iZ   (for subpopulation group mixing). These 
matrices provide the likelihood of mixing and are given by the following expressions:  
/
/
, ', ' , '
/
/
( ', ') ( ', ') ( ', ') ( ', ') ( ', ')
( ', ') ( ', ') ( ', ') ( ', ')
(1 )
( '', ') ( '', ') ( '', ') ( '', ') ( '', ')
( '', ') ( '', ') (
A M S C
A M S C
a a i Age a a Age
A M S C
A M S C
S a i E a i I a i I a i I a i
D a i D a i D a i R a i
H e e
S a i E a i I a i I a i I a i
D a i D a i D a

+ + + +
+ + + +
= + −
+ + + +
+ + +1 '', ') ( '', ')
agen








0                        if 
1,     where W=
    if 
1














,a a   (and ,i i  ) is the identity matrix.  0,1Agee   measures the degree of assortativeness in 
the age mixing. At the extreme 0Agee = , the mixing is fully proportional, while at the other 
extreme, 1Agee = , the mixing is fully assortative, that is individuals mix only with members in 
their own age group. W  is the subpopulation connectivity matrix of dimension pop popn n  and the 
mixing is assumed symmetric for all subpopulations. The W  matrix normalizes to 1, that is the 
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sum of all entries adds up to 1. q  parametrizes the connectivity to other subpopulations relative 
to the connectivity within the same subpopulation. 
II. Model fitting and parameter values 
The model was fitted to the following sources of data: 1) time-series of the number of 
polymerase chain reaction (PCR) laboratory-confirmed SARS-CoV-2 cases, 2) time-series of 
SARS-CoV-2 testing PCR positivity rate in each nationality subpopulation, 3) time-series of 
PCR positivity rate in symptomatic patients with suspected SARS-CoV-2 infection presenting to 
primary healthcare centers, 4) time-series of proportion of laboratory-confirmed SARS-CoV-2 
cases aged >60 years, 5) time-series of new/daily hospital admissions in acute-care beds and in 
ICU-care beds, 6) proportion of acute-care bed cases transferred subsequently to ICU-care beds, 
7) time-series of hospital occupancy in acute-care beds and in ICU-care beds, 8) cumulative 
number of deaths (not time series with the relatively small number of deaths), 9) one community 
survey assessing active-infection using PCR, 10) age-distribution of antibody positivity [4,8,9], 
and 11) nationality subpopulation distribution of antibody positivity [4,8,9]. 
Model input parameters were based on best available empirical data for SARS-CoV-2 natural 
history and epidemiology. Model parameter values are listed in Table 2. The following 
parameters were derived by fitting the model to data: 
Cf , S , C , SC , , ( )a , ( )i , Agee , q , 
0a , 1a , 2a , 0b , 1b , 2b , 0t , 1c , and 2c . 
Table S2. Model parameter values. 
Parameter Symbol Value Justification 
Duration of latent infection 
 
1/  3.69 days Based on existing estimate [10] and based 
on a median incubation period of 5.1 days 
[11] adjusted by observed viral load 
among infected persons [12] and reported 
transmission before onset of symptoms 
[13]. 
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Duration of infectiousness 
 
1/ AD  
1/ SD  
1/ CD  
3.48 days Based on existing estimate[10] and based 
on observed time to recovery among 
persons with mild infection [10,14] and 
observed viral load in infected persons 
[12,13,15].
 
Life expectancy in Qatar 1/   80.7 years United Nations World Population 
Prospects database [7]. 
Disease mortality rate in each 
age group  
( )a   The distribution and age dependence of 
COVID-19 mortality was based on the 
modeled SARS-CoV-2 epidemic in 
France [16].  
  Age 0-19 years 1RRD   1 0.1RRD =  Model-estimated relative risk of death 
based on the SARS-CoV-2 epidemic in 
France [16]. 
  Age 20-29 years 2RRD   2 0.4RRD =  Model-estimated relative risk of death 
based on the SARS-CoV-2 epidemic in 
France [16]. 
  Age 30-39 years   Reference 
category 
Model fitting 
  Age 40-49 years 3RRD   3 3.0RRD =  Model-estimated relative risk of death 
based on the SARS-CoV-2 epidemic in 
France [16]. 
  Age 50-59 years 4RRD   4 10.0RRD =  Model-estimated relative risk of death 
based on the SARS-CoV-2 epidemic in 
France [16]. 
  Age 60-69 years 5RRD   5 45.0RRD =  Model-estimated relative risk of death 
based on the SARS-CoV-2 epidemic in 
France [16]. 
  Age 70-79 years 6RRD   6 120.0RRD =  Model-estimated relative risk of death 
based on the SARS-CoV-2 epidemic in 
France [16]. 
  Age 80+ years 7RRD   7 505.0RRD =  Model-estimated relative risk of death 
based on the SARS-CoV-2 epidemic in 
France [16]. 
Proportion of infections that will 
progress to be infections that 
require hospitalization in acute-
care beds 
( )Sf a   The distribution and age dependence of 
asymptomatic/mild, severe, or critical 
infections was based on the modeled 
SARS-CoV-2 epidemic in France [16]. 
 
  Age 0-19 years ( )1 SRRS f t  1 0.1RRS =  Model-estimated relative risk of severe 
infection based on the SARS-CoV-2 
epidemic in France [16]. 
  Age 20-29 years ( )2 SRRS f t  2 0.5RRS =  Model-estimated relative risk of severe 
infection based on the SARS-CoV-2 
epidemic in France [16].
 








Sf t a e
 −
−  
 =  
Reference 
category 
This parameter was described by a 
Gaussian function, as it provided the best 
fit for the data of the daily hospital 
admissions in acute-care beds. 
  Age 40-49 years ( )3 SRRS f t  3 1.2RRS =  Model-estimated relative risk of severe 
infection based on the SARS-CoV-2 
epidemic in France [16]. 
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  Age 50-59 years ( )4 SRRS f t  4 2.3RRS =  Model-estimated relative risk of severe 
infection based on the SARS-CoV-2 
epidemic in France [16]. 
  Age 60-69 years ( )5 SRRS f t  5 4.5RRS =  Model-estimated relative risk of severe 
infection based on the SARS-CoV-2 
epidemic in France [16]. 
  Age 70-79 years ( )6 SRRS f t  6 7.8RRS =  Model-estimated relative risk of severe 
infection based on the SARS-CoV-2 
epidemic in France [16]. 
  Age 80+ years ( )7 SRRS f t  7 27.6RRS =  Model-estimated relative risk of severe 
infection based on the SARS-CoV-2 
epidemic in France [16]. 
Proportion of infections that will 
progress to be infections that 
require hospitalization in 
intensive care unit beds 
( )Cf a   
The distribution and age dependence of 
asymptomatic/mild, severe, or critical 
infections was based on the modeled 
SARS-CoV-2 epidemic in France [16].
 
  Age 0-19 years 1 CRRC f  1 0.2RRC =   Model-estimated relative risk of critical 
infection based on the SARS-CoV-2 
epidemic in France [16]. 
  Age 20-29 years 2 CRRC f  2 0.3RRC =  Model-estimated relative risk of critical 
infection based on the SARS-CoV-2 
epidemic in France [16].
 
  Age 30-39 years 
Cf   Reference 
category 
Model fitting 
  Age 40-49 years 3 CRRC f  3 1.8RRC =  Model-estimated relative risk of critical 
infection based on the SARS-CoV-2 
epidemic in France [16].
 
  Age 50-59 years 4 CRRC f  4 4.7RRC =  Model-estimated relative risk of critical 
infection based on the SARS-CoV-2 
epidemic in France [16].
 
  Age 60-69 years 5 CRRC f  5 10.6RRC =  Model-estimated relative risk of critical 
infection based on the SARS-CoV-2 
epidemic in France [16].
 
  Age 70-79 years 6 CRRC f  6 13.6RRC =  Model-estimated relative risk of critical 
infection based on the SARS-CoV-2 
epidemic in France [16]. 
  Age 80+ years 7 CRRC f  7 8.7RRC =  Model-estimated relative risk of critical 
infection based on the SARS-CoV-2 
epidemic in France [16]. 
 
III. Basic reproduction number 
0R  and effective reproduction number tR   
As informed by the method of Heffernan and et al. [17], the overall basic reproduction number (
0R ) and overall effective reproduction number ( tR ) were derived to be 
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TotN  is the total population size and ( ),N a i  is the population size of each age group a  
and subpopulation group i .  
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Figure S2. Model fits to (A) SARS-CoV-2 laboratory-confirmed cases and (B) testing PCR 
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Figure S3. Model fits to A) daily hospital admissions in acute-care beds, B) daily hospital 
admissions in ICU-care beds, C) hospital occupancy of COVID-19 patients (number of beds 
occupied at any given time) in acute-care beds, and D) hospital occupancy of COVID-19 patients 
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Figure S4. Evolution of the basic reproduction number R0 (A) and effective reproduction 
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Figure S5. Impact of the social and physical distancing interventions on A) cumulative number 
of infections, B) cumulative number of deaths, C) cumulative number of hospital admissions in 
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Figure S6. Uncertainty analysis. Mean and 95% uncertainty interval (UI) for the evolution of 
SARS-CoV-2 A) incidence (number of daily new infections), B) cumulative number of 
infections, C) active-infection prevalence (those latently infected or infectious), and D) attack 
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Figure S7. Uncertainty analysis. Mean and 95% uncertainty interval (UI) for the evolution of 
COVID-19 A) daily hospital admissions in acute-care beds, B) daily hospital admissions in ICU-
care beds, C) cumulative number of hospitalizations in acute-care beds, D) cumulative number of 
hospitalizations in ICU-care beds, E) hospital occupancy of COVID-19 patients (number of beds 
occupied at any given time) in acute-care beds, and F) hospital occupancy of COVID-19 patients 
in ICU-care beds. 
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